Utility of in vitro interferon‐γ release assay in differential diagnosis between intestinal tuberculosis and Crohn's disease
- 23 November 2012
- journal article
- research article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 14 (2), 68-75
- https://doi.org/10.1111/1751-2980.12017
Abstract
Objective To evaluate the diagnostic utility of interferon-γ release assay (T-SPOT.TB) for the differential diagnosis between Crohn's disease (CD) and intestinal tuberculosis (ITB). Methods A total of 103 CD and 88 ITB patients, confirmed by histology and anti-tuberculosis treatment response from 2003 to 2011, were included. Their characteristics and clinical features were recorded. Mycobacterium tuberculosis (MTB) polymerase chain reaction (PCR) of IS6110, in vitro T-SPOT.TB, tuberculin skin test (TST), immunoglobulin G (IgG) antibody to MTB (protein chip), serum anti-Saccharomyces cerevisiae antibodies (ASCA IgG, chronic inflammatory bowel disease profile) and acid-fast staining of biopsied colonic tissue specimens were performed. Statistical analysis was conducted to determine their concordance with the diagnosis and its sensitivity, specificity, positive (PPV) and negative predictive value (NPV). Results Abnormal pulmonary X-ray, ascites and lesions of both cecum and ascending colon were more associated with ITB, while intestinal surgery and lesions of both ileum and adjacent colon were more commonly seen in CD. Significant diagnostic concordance was found using T-SPOT.TB (κ = 0.786) by consistency test. The sensitivity, specificity, PPV and NPV of T-SPOT.TB were 86%, 93%, 88% and 91%, respectively, and the sensitivity and NPV were significantly higher than other examinations (P < 0.05). Conclusion T-SPOT.TB is a valuable assay in differentiating ITB from CD, particularly in the diagnostic exclusion of ITB based on its high specificity and NPV.Keywords
This publication has 31 references indexed in Scilit:
- Evaluation of Gamma Interferon Release Assays Using Mycobacterium tuberculosis Antigens for Diagnosis of Latent and Active Tuberculosis in Mycobacterium bovis BCG-Vaccinated PopulationsClinical and Vaccine Immunology, 2010
- The Role of Bacteria in the Pathogenesis of Inflammatory Bowel DiseaseGut and Liver, 2010
- Evaluation of Molecular Tools for Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Stool Specimens from Patients with Pulmonary TuberculosisJournal of Clinical Microbiology, 2010
- The Usefulness of In Vitro Interferon-γ Assay for Differential Diagnosis between Intestinal Tuberculosis and Crohn's DiseaseThe Korean Journal of Gastroenterology, 2010
- The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosiscclm, 2009
- IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in FinlandBMC Research Notes, 2009
- Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective studyBMC Infectious Diseases, 2008
- Interferon- Release Assays Improve the Diagnosis of Tuberculosis and Nontuberculous Mycobacterial Disease in Children in a Country with a Low Incidence of TuberculosisClinical Infectious Diseases, 2007
- Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γEmerging Infectious Diseases, 2007
- PCR Amplification of the IS 6110 Insertion Element of Mycobacterium tuberculosis in Fecal Samples from Patients with Intestinal TuberculosisJournal of Clinical Microbiology, 2006